← Back to Search

Behavioral Intervention

iPeer2Peer Mentorship for Juvenile Idiopathic Arthritis (iPeer2Peer Trial)

N/A
Waitlist Available
Led By Jennifer N Stinson, CPNP, PhD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; immediately following interview (approximately 12 weeks after baseline); 6-months post
Awards & highlights

iPeer2Peer Trial Summary

This trial will compare the effects of the iPeer2Peer program (teens with arthritis matched to an older mentor) to a control group (teens with arthritis with no mentor) on measures of disease activity, quality of life, and psychological outcomes.

Eligible Conditions
  • Juvenile Idiopathic Arthritis

iPeer2Peer Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; immediately following interview (approximately 12 weeks after baseline); 6-months post
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; immediately following interview (approximately 12 weeks after baseline); 6-months post for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
TRANSITION-Q (measuring change)
Secondary outcome measures
AQoL-6D, interview (measuring change)
Center for Epidemiologic Studies Depression Scale Revised (measuring change)
Children's Arthritis Self-Efficacy (measuring change)
+11 more

iPeer2Peer Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: iPeer2Peer MentorshipExperimental Treatment1 Intervention
In addition to standard care, youth in the experimental group will receive the iPeer2Peer program, a peer mentorship program that will provide modeling and reinforcement of self-management by pre-screened and trained peer mentors (young adults with JIA aged 18-22 years who have learned to function successfully with their disease). Mentors will encourage participants to develop and engage in self-management skills and provide social support.
Group II: Control GroupActive Control1 Intervention
The control group will receive standard care but without the iPeer2Peer program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
iPeer2Peer Mentorship
2017
N/A
~170

Find a Location

Who is running the clinical trial?

Provincial Health Services AuthorityOTHER
39 Previous Clinical Trials
31,431 Total Patients Enrolled
The Hospital for Sick ChildrenLead Sponsor
686 Previous Clinical Trials
6,944,629 Total Patients Enrolled
IWK Health CentreOTHER
125 Previous Clinical Trials
100,309 Total Patients Enrolled

Media Library

iPeer2Peer Program (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03116763 — N/A
Juvenile Idiopathic Arthritis Research Study Groups: iPeer2Peer Mentorship, Control Group
Juvenile Idiopathic Arthritis Clinical Trial 2023: iPeer2Peer Program Highlights & Side Effects. Trial Name: NCT03116763 — N/A
iPeer2Peer Program (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03116763 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many persons are participating in this research project?

"To complete this medical trial, 262 eligible patients will be needed. Participants have the choice of being enrolled at either BC Children's Hospital in Vancouver or The IWK Health Centre in Halifax."

Answered by AI

Who is qualified to participate in this clinical experiment?

"This medical investigation is looking for 262 participants between the ages of 12 and 18, who have been diagnosed with juvenile arthritis."

Answered by AI

Is eligibility for this research initiative limited to individuals beyond the age of 45?

"The minimum age of admittance to this trial is 12, while the maximum allowable enrolment age is 18."

Answered by AI

What is the current geographic distribution of this trial?

"This clinical investigation is recruiting participants from BC Children's Hospital in Vancouver, IWK Health Centre in Halifax and the London Health Sciences' Children's Hospital of Ontario. An additional 6 sites are also taking part."

Answered by AI

Is enrollment in this trial currently accessible?

"The protocol, which was initially posted on March 28th 2017 and last edited October 24th 2022 is currently recruiting participants."

Answered by AI
~20 spots leftby Apr 2025